These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24879585)

  • 1. In vitro studies of the activity of dithiocarbamate organoruthenium complexes against clinically relevant fungal pathogens.
    Donnici CL; Nogueira LJ; Araujo MH; Oliveira SR; Magalhães TF; Lopes MT; Araújo e Silva AC; Ferreira AM; Martins CV; de Resende Stoianoff MA
    Molecules; 2014 Apr; 19(4):5402-20. PubMed ID: 24879585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
    Pfaller MA; Carvalhaes C; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
    Del Poeta M; Bixel AS; Barchiesi F; Tidwell RR; Boykin D; Scalise G; Perfect JR
    J Antimicrob Chemother; 1999 Aug; 44(2):223-8. PubMed ID: 10473229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Int J Antimicrob Agents; 2017 Sep; 50(3):352-358. PubMed ID: 28689871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structural characterization, and prospects for new cobalt (II) complexes with thiocarbamoyl-pyrazoline ligands as promising antifungal agents.
    Dias BB; da Silva Dantas FG; Galvão F; Cupozak-Pinheiro WJ; Wender H; Pizzuti L; Rosa PP; Tenório KV; Gatto CC; Negri M; Casagrande GA; de Oliveira KMP
    J Inorg Biochem; 2020 Dec; 213():111277. PubMed ID: 33045593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans.
    Barchiesi F; Del Poeta M; Morbiducci V; Ancarani F; Scalise G
    Mycopathologia; 1993 Oct; 124(1):19-25. PubMed ID: 8159215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flucytosine primary resistance in Candida species and Cryptococcus neoformans.
    Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Rodríguez-Tudela JL
    Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):276-9. PubMed ID: 11399020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal pathogens.
    Zhang JD; Cao YB; Xu Z; Sun HH; An MM; Yan L; Chen HS; Gao PH; Wang Y; Jia XM; Jiang YY
    Biol Pharm Bull; 2005 Dec; 28(12):2211-5. PubMed ID: 16327151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
    Pfaller MA; Messer SA; Jones RN; Castanheira M
    J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activities of compounds isolated from Piper abutiloides Kunth.
    Johann S; Cota BB; Souza-Fagundes EM; Pizzolatti MG; Resende MA; Zani CL
    Mycoses; 2009 Nov; 52(6):499-506. PubMed ID: 19076283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal promising agents of zinc(II) and copper(II) derivatives based on azole drug.
    de Azevedo-França JA; Borba-Santos LP; de Almeida Pimentel G; Franco CHJ; Souza C; de Almeida Celestino J; de Menezes EF; Dos Santos NP; Vieira EG; Ferreira AMDC; de Souza W; Rozental S; Navarro M
    J Inorg Biochem; 2021 Jun; 219():111401. PubMed ID: 33756392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.